These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1339191)
21. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Le Beau MM; Lemons RS; Espinosa R; Larson RA; Arai N; Rowley JD Blood; 1989 Feb; 73(3):647-50. PubMed ID: 2783863 [TBL] [Abstract][Full Text] [Related]
22. Oncogene involvement in myelodysplasia and acute myeloid leukemia. Sheridan BL; Reis MD Tumour Biol; 1990; 11 Suppl 1():44-58. PubMed ID: 2247755 [TBL] [Abstract][Full Text] [Related]
23. Unbalanced translocations of 20q in AML and MDS often involve interstitial rather than terminal deletions of 20q. MacKinnon RN; Duivenvoorden HM; Campbell LJ Cancer Genet; 2011 Mar; 204(3):153-61. PubMed ID: 21504715 [TBL] [Abstract][Full Text] [Related]
24. The unexplored 5q13 locus: a role in hematopoietic malignancies. Castro PD; Fairman J; Nagarajan L Leuk Lymphoma; 1998 Aug; 30(5-6):443-8. PubMed ID: 9711906 [TBL] [Abstract][Full Text] [Related]
25. [Aberrations of chromosome 5 in myeloid malignancies with complex chromosome abnormalities]. Liu Q; Xu W; Zhu Y; Fan L; Qiu HR; Wang R; Qiao C; Li JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1257-60. PubMed ID: 19099622 [TBL] [Abstract][Full Text] [Related]
26. A new nonrandom unbalanced t(17;20) in myeloid malignancies. Patsouris C; Michael PM; Campbell LJ Cancer Genet Cytogenet; 2002 Oct; 138(1):32-7. PubMed ID: 12419582 [TBL] [Abstract][Full Text] [Related]
27. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia. Bram S; Swolin B; Rödjer S; Stockelberg D; Ogärd I; Bäck H Cancer Genet Cytogenet; 2003 Apr; 142(2):107-14. PubMed ID: 12699885 [TBL] [Abstract][Full Text] [Related]
28. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. MacKinnon RN; Kannourakis G; Wall M; Campbell LJ Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236 [TBL] [Abstract][Full Text] [Related]
29. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464 [TBL] [Abstract][Full Text] [Related]
30. Absence of point mutations within the AML-1 gene in patients with MDS/AML and loss of chromosome 5q or 7. Ferrari T; Weber B; Pils S; Harbott J; Borkhardt A Ann Hematol; 2001 Feb; 80(2):72-3. PubMed ID: 11261327 [TBL] [Abstract][Full Text] [Related]
31. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Andreasson P; Johansson B; Arheden K; Billström R; Mitelman F; Höglund M Genes Chromosomes Cancer; 1997 Jun; 19(2):77-83. PubMed ID: 9171997 [TBL] [Abstract][Full Text] [Related]
32. 5q-, twenty-five years later: a synopsis. Van den Berghe H; Michaux L Cancer Genet Cytogenet; 1997 Mar; 94(1):1-7. PubMed ID: 9078284 [TBL] [Abstract][Full Text] [Related]
33. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment. Pedersen B Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400 [TBL] [Abstract][Full Text] [Related]
34. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia. Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000 [TBL] [Abstract][Full Text] [Related]
35. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression. Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965 [TBL] [Abstract][Full Text] [Related]
36. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion. Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333 [TBL] [Abstract][Full Text] [Related]
37. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Lezon-Geyda K; Najfeld V; Johnson EM Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483 [TBL] [Abstract][Full Text] [Related]
38. The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53 mutations. Stengel A; Kern W; Haferlach T; Meggendorfer M; Haferlach C Genes Chromosomes Cancer; 2016 Oct; 55(10):777-85. PubMed ID: 27218649 [TBL] [Abstract][Full Text] [Related]
39. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders. Bram S; Rödjer S; Swolin B Cancer Genet Cytogenet; 2004 Nov; 155(1):74-8. PubMed ID: 15527906 [TBL] [Abstract][Full Text] [Related]